Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada
- Conditions
- Chronic Venous Insufficiency
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Intervene, Inc.
- Registration Number
- NCT05047302
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US
- Conditions
- Deep Vein RefluxChronic Venous Insufficiency (CVI)
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04225806
- Locations
- 🇺🇸
The Vascular Experts, Darien, Connecticut, United States
🇺🇸NYU Langone Medical Center, New York, New York, United States
🇺🇸University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System
- Conditions
- Chronic Venous Insufficiency
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2021-09-10
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03216005
- Locations
- 🇦🇺
Royal Prince Alfred, Camperdown, New South Wales, Australia
🇦🇺Prince of Wales, Randwick, New South Wales, Australia
🇨🇦Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
A Feasibility Study of the ReLeaf Catheter System
- Conditions
- Chronic Venous Insufficiency
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Intervene, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT02462096
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, New Zealand